Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
暂无分享,去创建一个
Webster K. Cavenee | Yonghong Xiao | Michael R. Stratton | Keith L. Ligon | Lynda Chin | William C. Hahn | Cameron Brennan | Koichi Ichimura | Gerald C. Chu | Alexei Protopopov | L. Chin | W. Hahn | M. Stratton | A. Protopopov | Yonghong Xiao | C. Brennan | G. Bignell | K. Ligon | W. Cavenee | F. Furnari | G. Chu | K. Ichimura | T. Heffernan | P. A. Futreal | Hongwu Zheng | R. Wiedemeyer | Ruprecht Wiedemeyer | Graham Bignell | Frank Furnari | P. Andrew Futreal | V. Peter Collins | Timothy P. Heffernan | Hongwu Zheng | John Mahoney | V. Collins | John A Mahoney | Andrew P Futreal | Lynda Chin | Cameron Brennan | Peter Collins
[1] L. Chin,et al. High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[3] Andrey Korshunov,et al. Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH) , 2006, Acta Neuropathologica.
[4] L. Chin,et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers , 2007, Nature.
[5] A. Berns,et al. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a , 2007, Nature.
[6] U. Lendahl,et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. , 2007, Cancer research.
[7] A. Merlo,et al. Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines. , 1999, Brain pathology.
[8] Peter J. Park,et al. Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data , 2005, Bioinform..
[9] Dejan Juric,et al. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. , 2005, Cancer research.
[10] Yuri Kotliarov,et al. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. , 2006, Cancer research.
[11] N. Carter,et al. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH , 2006, Oncogene.
[12] L. Chin,et al. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. , 2007, Genes & development.
[13] K. Frazer,et al. Common deletions and SNPs are in linkage disequilibrium in the human genome , 2006, Nature Genetics.
[14] K. Aldape,et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. , 2005, Cancer research.
[15] D. Conrad,et al. A high-resolution survey of deletion polymorphism in the human genome , 2006, Nature Genetics.
[16] José Luis de la Pompa,et al. Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.
[17] E. Eichler,et al. Segmental duplications and copy-number variation in the human genome. , 2005, American journal of human genetics.
[18] D. Carrasco,et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. , 2007, Cancer research.
[19] Fenghua Liu,et al. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. , 2006, Cancer research.
[20] Keith L. Ligon,et al. Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies , 2007, Science.
[21] Andrew D. Yates,et al. Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.
[22] L. Chin,et al. A Comparison of DNA Copy Number Profiling Platforms , 2007 .
[23] Daniel A. Haber,et al. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines , 2001, Nature.
[24] Allan Balmain,et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene , 2004, Nature.
[25] E. S. Venkatraman,et al. A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..
[26] L. Chin,et al. High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] N. Sharpless,et al. The Regulation of INK4/ARF in Cancer and Aging , 2006, Cell.
[28] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[29] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[30] Koji Yoshimoto,et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. , 2005, The New England journal of medicine.
[31] L. Hawthorn,et al. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme , 2005, Genes, chromosomes & cancer.
[32] M. Ringnér,et al. Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.
[33] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[34] Erwin G. Van Meir,et al. Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). , 2003, International journal of oncology.
[35] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[36] O. Tachibana,et al. Frequent LOH at Chromosome 12q22‐23 and Apaf‐1 Inactivation in Glioblastoma , 2003, Brain pathology.
[37] A. Blais,et al. Regulation of the Human Cyclin-dependent Kinase Inhibitor p18 INK4c by the Transcription Factors E2F1 and Sp1* , 2002, The Journal of Biological Chemistry.
[38] Maylis Delugin,et al. FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients , 2007, Cell Division.
[39] L. Chin,et al. A comparison of DNA copy number profiling platforms. , 2008, Cancer research.
[40] W. Cavenee,et al. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[42] Pardis C Sabeti,et al. Common deletion polymorphisms in the human genome , 2006, Nature Genetics.
[43] L. Chin,et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. , 2006, Cancer cell.
[44] Forest M White,et al. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma , 2007, Proceedings of the National Academy of Sciences.
[45] E. Eichler,et al. Fine-scale structural variation of the human genome , 2005, Nature Genetics.
[46] J. Massagué,et al. G1 cell-cycle control and cancer , 2004, Nature.
[47] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[48] N. Carter,et al. Genomic Profiling Identifies Discrete Deletions Associated with Translocations in Glioblastoma Multiforme , 2006, Cell cycle.
[49] Rebecca A Betensky,et al. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] F. McCormick,et al. The RB and p53 pathways in cancer. , 2002, Cancer cell.
[51] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[52] P. A. Futreal,et al. Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment , 2007, Clinical Cancer Research.